Digoxin Attenuates Acute Cardiac Allograft Rejection by Antagonizing RORγt Activity

Abstract

RORγt may be a promising therapeutic target to attenuate acute cardiac allograft rejection. Digoxin therefore provides a molecular basis for the design of novel immunosuppressive agents.